Skip to main content

Table 2 Life years gained and medication costs incurred per treatment arm and age group

From: Using cost-effectiveness analysis to support policy change: varenicline and nicotine replacement therapy for smoking cessation in Jordan

  Cost (in JDs) Life years Number intending to quit Cycles
Age 30–34
 Varenicline 33,043,140 2,829,590 123,476 40
 NRT 23,497,344 2,815,827 123,476 40
 Brief counseling 2,570,022 2,797,447 123,476 40
Age 35–39
 Varenicline 29,199,690 2,013,904 109,453 35
 NRT 20,764,224 2,004,786 109,453 35
 Brief counseling 2,271,087 1,986,592 109,453 35
Age 40–44
 Varenicline 24997680 1330153 95,062 30
 NRT 17776128 1321244 95,062 30
 Brief counseling 1944264 1306761 95,062 30
Age 45–49
 Varenicline 20,887,200 825,156 80,768 25
 NRT 14,853,120 820,792 80,768 25
 Brief counseling 1,624,560 812,682 80,768 25
Age 50–54
 Varenicline 14668560 408252 59,340 20
 NRT 10430976 405324 59,340 20
 Brief counseling 1140888 402227 59,340 20
Age 55–59
 Varenicline 9,338,760 182,218 40,366 15
 NRT 6,640,896 181,688 40,366 15
 Brief counseling 726,348 180,711 40,366 15
Age 60–64
 Varenicline 2,271,510 32,060 10,883 10
 NRT 1,615,296 31,897 10,883 10
 Brief counseling 176,613 31,363 10,883 10
Age 65–70
 Varenicline 1,342,170 13,045 7770 5
 NRT 954,432 12,880 7770 5
 Brief counseling 104,391 12,625 7770 5
Total
 Varenicline 135,748,710 7,625,378 527,118 180
 NRT 96,532,416 7,594,438 527,118 180
 Brief counseling 10,558,173 7,530,408 527,118 180